Concepedia

Esther M. van Wezel

EM

6

Publications

150

Citations

6

H-Index

2014

Active since

Affiliations

Sanquin(Current)

University Hospital Cologne

University of Cologne

Emma Kinderziekenhuis

University of Amsterdam

Esther M. van Wezel is an author at Sanquin specializing in medicine, pathology, and health sciences.

Top concepts

Publications per year

2014–2020

6

Publications

6

Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel

Esther M. van Wezel, Lieke M. J. van Zogchel, Jalenka van Wijk et al. · JCO Precision Oncology · 2019 · 36 citations · Full text

, , +20

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response

Esther M. van Wezel, Joep de Bruijne, Kevin Damman et al. · Open Forum Infectious Diseases · 2019 · 27 citations · Full text

Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma

Esther M. van Wezel, Janine Stutterheim, Florentien M. Vree et al. · Pediatric Blood & Cancer · 2015 · 26 citations

Hypermethylated <i>RASSF1A</i> as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma

Lieke M. J. van Zogchel, Esther M. van Wezel, Jalenka van Wijk et al. · JCO Precision Oncology · 2020 · 23 citations · Full text

Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma

Esther M. van Wezel, Danny A. Zwijnenburg, Lily Zappeij‐Kannegieter et al. · Journal of Molecular Diagnostics · 2014 · 21 citations

, , +8

Rows per page

1–5 of 6